SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 16, 2004
SERACARE LIFE SCIENCES, INC.
(Exact name of registrant as specified in its charter)
| | | | |
| California | | 0-33045 | | 33-0056054 |
(State or other jurisdiction of incorporation) | | (Commission File Number) | | (I.R.S. Employer Identification No.) |
| | |
1935 Avenida del Oro, Suite F Oceanside, California | | 92056 |
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code: (760) 806-8922
N/A
(Former name or former address, if changed since last report)
Item 12. Results of Operations and Financial Condition.
On August 16, 2004, SeraCare Life Sciences, Inc. issued a press release announcing its financial results for its fiscal quarter ended June 30, 2004. A copy of the press release is furnished as Exhibit 99.1 to this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | |
| | | SERACARE LIFE SCIENCES, INC. |
| | |
| Date: August 16, 2004 | | By: | | /s/ Tim T. Hart
|
| | | | | Tim T. Hart |
| | | | | Chief Financial Officer |
INDEX OF EXHIBITS
| | |
Exhibit No.
| | Description
|
| 99.1 | | Press Release issued on August 16, 2004. |
